Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcoma
about
Advances in the management of osteosarcomaAssessment of GSK1904529A as a promising anti-osteosarcoma agent.ERK inhibition sensitizes CZ415-induced anti-osteosarcoma activity in vitro and in vivo.Advances in the Treatment of Pediatric Bone Sarcomas.DOX-Vit D, a Novel Doxorubicin Delivery Approach, Inhibits Human Osteosarcoma Cell Proliferation by Inducing Apoptosis While Inhibiting Akt and mTOR Signaling Pathways
P2860
Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcoma
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcoma
@ast
Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcoma
@en
Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcoma
@nl
type
label
Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcoma
@ast
Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcoma
@en
Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcoma
@nl
prefLabel
Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcoma
@ast
Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcoma
@en
Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcoma
@nl
P2860
P3181
P1433
P1476
Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcoma
@en
P2093
Katherine A Janeway
Michael W Bishop
P2860
P3181
P356
10.12688/F1000RESEARCH.8228.1
P407
P577
2016-01-01T00:00:00Z